Abstract:Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disorder characterized by persistent airflow limitation and represents one of the leading causes of morbidity and mortality worldwide. Therefore, its prevention and management is urgent, and elucidating its pathogenesis is also crucial. Airway inflammation is a core factor in COPD progression, and inhibiting the airway inflammatory response has become one of the effective therapeutic approaches. Toll-like receptor 4 (TLR4) is involved in the initiation and development of airway inflammation. The nuclear factor kappa B (NF-κB) signaling pathway, serving as a core regulatory axis of inflammatory responses, mediates the activation of the NOD-like receptor protein 3 (NLRP3) inflammasome, thereby driving the precise processing, maturation, and release of inflammatory factors. TLR4, NF-κB, and the NLRP3 inflammasome interact synergistically, forming a complex signal transduction cascade network that plays a key regulatory role in airway inflammatory response. Based the TLR4/NF-κB/NLRP3 signaling pathway, this review explores the mechanism by which inflammatory factors produced by airway inflammatory cells in the development and progression of COPD, offering potential new targets for the diagnosis, treatment, and prevention of COPD.